Exploring the association between bipolar disorder and uric acid: A mediation analysis

Journal of Psychosomatic Research

Volumn 84, Issue , 2016, Pages 56-59

  Bartoli, Francesco ^a   Crocamo, Cristina ^a   Gennaro, Giulia Maria ^a   Castagna, Gloria ^a   Trotta, Giulia ^a   Clerici, Massimo ^a   Carrà, Giuseppe ^a,b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bipolar disorder; Mediation analysis; Metabolic syndrome; Purinergic system; Uric acid

Indexed keywords

TRIACYLGLYCEROL; URIC ACID;

ABDOMINAL CIRCUMFERENCE; ADULT; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; EXPLORATORY RESEARCH; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; BLOOD; COMPLICATION; CROSS-SECTIONAL STUDY; YOUNG ADULT;

ADULT; BIPOLAR DISORDER; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; URIC ACID; YOUNG ADULT;

EID: 84962360688     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2016.03.014     Document Type: Article

References (32)

1. Grassi D., Ferri L., Desideri G., Di Giosia P., Cheli P., Del Pinto R., Properzi G., Ferri C. Chronic hyperuricemia, uric acid deposit and cardiovascular risk. Curr. Pharm. Des. 2013, 19:2432-2438.
2. Burnstock G. Purinergic signalling and disorders of the central nervous system. Nat. Rev. Drug Discov. 2008, 7:575-590.
3. Zarate C.A., Manji H.K. Bipolar disorder: candidate drug targets. Mt Sinai J. Med. 2008, 75:226-247.
4. Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev. 2007, 87:659-797.
5. Ortiz R., Ulrich H., Zarate C.A., Machado-Vieira R. Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2015, 57:117-131.
6. Machado-Vieira R., Lara D.R., Souza D.O., Kapczinski F. Purinergic dysfunction in mania: an integrative model. Med. Hypotheses 2002, 2002(58):297-304.
7. Albert U., De Cori D., Aguglia A., Barbaro F., Bogetto F., Maina G. Increased uric acid levels in bipolar disorder subjects during different phases of illness. J. Affect. Disord. 2015, 173:170-175.
8. Salvadore G., Viale C.I., Luckenbaugh D.A., Zanatto V.C., Portela L.V., Souza D.O., Zarate C.A., Machado-Vieira R. Increased uric acid levels in drug-naïve subjects with bipolar disorder during a first manic episode. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2010, 34:819-821.
9. Kesebir S., Tatlidil Yaylaci E., Süner O., Gültekin B.K. Uric acid levels may be a biological marker for the differentiation of unipolar and bipolar disorder: the role of affective temperament. J. Affect. Disord. 2014, 165:131-134.
10. Vancampfort D., Vansteelandt K., Correll C.U., Mitchell A.J., De Herdt A., Sienaert P., Probst M., De Hert M. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am. J. Psychiatry 2013, 170:265-274.
11. Puig J.G., Martínez M.A. Hyperuricemia, gout and the metabolic syndrome. Curr. Opin. Rheumatol. 2008, 20:187-191.
12. Yuan H., Yu C., Li X., Sun L., Zhu X., Zhao C., Zhang Z., Yang Z. Serum uric acid levels and risk of metabolic syndrome: a dose-response meta-Analysis of prospective studies. J. Clin. Endocrinol. Metab. 2015, 100:4198-4207.
13. Chiu C.C., Chen C.H., Huang M.C., Chen P.Y., Tsai C.J., Lu M.L. The relationship between serum uric acid concentration and metabolic syndrome in patients with schizophrenia or schizoaffective disorder. J. Clin. Psychopharmacol. 2012, 32:585-592.
14. Godin O., Leboyer M., Gaman A., Aouizerate B., Berna F., Brunel L., Capdevielle D., Chereau I., Dorey J.M., Dubertret C., Dubreucq J., Faget C., Gabayet F., Le Strat Y., Llorca P.M., Misdrahi D., Rey R., Richieri R., Passerieux C., Schandrin A., Schürhoff F., Urbach M., Vidalhet P., Girerd N., Fond G., FACE-SZ group Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: results from the FACE-SZ cohort. Schizophr. Res. 2015, 168:388-394.
15. Bortolasci C.C., Vargas H.O., Vargas Nunes S.O., de Melo L.G., de Castro M.R., Moreira E.G., Dodd S., Barbosa D.S., Berk M., Maes M. Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder. J. Affect. Disord. 2015, 179:148-155.
16. McElroy S.L., Keck P.E. Metabolic syndrome in bipolar disorder: a review with a focus on bipolar depression. J. Clin. Psychiatry 2014, 75:46-61.
17. von Elm E., Altman D.G., Egger M., Pocock S.J., Gøtzsche P.C., Vandenbroucke J.P., STROBE Initiative The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J. Clin. Epidemiol. 2008, 61:344-349.
18. Carrà G., Bartoli F., Carretta D., Crocamo C., Bozzetti A., Clerici M., Bebbington P.E. The prevalence of metabolic syndrome in people with severe mental illness: a mediation analysis. Soc. Psychiatry Psychiatr. Epidemiol. 2014, 49:1739-1746.
19. Clerici M., Bartoli F., Carretta D., Crocamo C., Bebbington P.E., Carrà G. Cardiovascular risk factors among people with severe mental illness in Italy: a cross-sectional comparative study. Gen. Hosp. Psychiatry 2014, 36:698-702.
20. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith S.C., Spertus J.A., Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
21. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., Fruchart J.C., James W.P., Loria C.M., Smith S.C. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
22. Sicras A., Rejas J., Navarro R., Serrat J., Blanca M. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a health management organization database. Bipolar Disord. 2008, 10:607-616.
23. Janssen I., Katzmarzyk P.T., Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am. J. Clin. Nutr. 2004, 79:379-384.
24. Staiano A.E., Reeder B.A., Elliott S., Joffres M.R., Pahwa P., Kirkland S.A., Paradis G., Katzmarzyk P.T. Body mass index versus waist circumference as predictors of mortality in Canadian adults. Int. J. Obes. 2012, 2012(36):1450-1454.
25. Imai K., Keele L., Tingley D. A general approach to causal mediation analysis. Psychol. Methods 2010, 15:309-334.
26. Lorenzi T.M., Borba D.L., Dutra G., Lara D.R. Association of serum uric acid levels with emotional and affective temperaments. J. Affect. Disord. 2010, 121:161-164.
27. Carrà G., Scioli R., Monti M.C., Marinoni A. Severity profiles of substance-abusing patients in Italian community addiction facilities: influence of psychiatric concurrent disorders. Eur. Addict. Res. 2006, 12:96-101.
28. de Oliveira E.P., Burini R.C. High plasma uric acid concentration: causes and consequences. Diabetol. Metab. Syndr. 2012, 4:4-12.
29. Kim S.Y., Guevara J.P., Kim K.M., Choi H.K., Heitjan D.F., Albert D.A. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res. (Hoboken) 2010, 62:170-180.
30. Hirota T., Kishi T. Adenosine hypothesis in schizophrenia and bipolar disorder: a systematic review and meta-analysis of randomized controlled trial of adjuvant purinergic modulators. Schizophr. Res. 2013, 149:88-95.
31. De Berardis D., Conti C.M., Campanella D., Carano A., Di Giuseppe B., Valchera A., Tancredi L., Serroni N., Pizzorno A.M., Fulcheri M., Gambi F., Sepede G., Moschetta F.S., Salerno R.M., Ferro F.M. Evaluation of plasma antioxidant levels during different phases of illness in adult patients with bipolar disorder. J. Biol. Regul. Homeost. Agents 2008, 22:195-200.
32. Muti M., Del Grande C., Musetti L., Marazziti D., Turri M., Cirronis M., Pergentini I., Corsi M., Dell'Osso L., Corsini G.U. Serum uric acid levels and different phases of illness in bipolar I patients treated with lithium. Psychiatry Res. 2015, 225:604-608.